Peanut Allergy Treatment Market Size, Share & Trends Analysis Report By Drug Class (Antihistamines, Epinephrine), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation
                       1.1.1. Market Definitions
                   1.2. Objectives
                       1.2.1. Objective - 1
                       1.2.2. Objective - 2
                       1.2.3. Objective - 3
                   1.3. Research Methodology
                   1.4. Information Procurement
                       1.4.1. Purchased Database
                       1.4.2. Gvr’s Internal Database
                       1.4.3. Secondary Sources
                       1.4.4. Primary Research
                   1.5. Information Or Data Analysis
                       1.5.1. Data Analysis Models
                   1.6. Market Formulation & Validation
                   1.7. Model Details
                       1.7.1. Commodity Flow Analysis
                   1.8. List of Secondary Sources
                   1.9. List of Abbreviations
                   1.10. List of Primary Sources
Chapter 2. Executive Summary
                   2.1. Market Snapshot
                   2.2. Drug Class and Route of Administration Snapshot
                   2.3. Distribution Channel Snapshot
                   2.4. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
                   3.1. Market Segmentation and Scope
                   3.2. Market Lineage Outlook
                       3.2.1. Parent Market Outlook
                       3.2.2. Related/Ancillary Market Outlook
                   3.3. Market Trends and Outlook
                   3.4. Market Dynamics
                       3.4.1. Rising product approvals for the treatment of peanut allergy
                       3.4.2. Increasing prevalence of peanut allergies
                       3.4.3. Increasing healthcare expenditure
                   3.5. Market Restraint Analysis
                       3.5.1. High cost of the treatment and the products
                   3.6. Business Environment Analysis
                       3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
                       3.6.2. Porter’s Five Forces Analysis
                   3.7. COVID-19 Impact Analysis
Chapter 4. Route Of Administration Business Analysis
                   4.1. Peanut Allergy Treatment Market: Route Of Administration Movement Analysis
                   4.2. Oral
                       4.2.1. Oral Market, 2018 - 2030 (USD Million)
                   4.3. Injectable
                       4.3.1. Injectable Market, 2018 - 2030 (USD Million)
                   4.4. Others
                       4.4.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. Drug Class Business Analysis
                   5.1. Peanut Allergy Treatment Market: Drug Class Movement Analysis
                   5.2. Antihistamines
                       5.2.1. Antihistamines Market, 2018 - 2030 (USD Million)
                   5.3. Epinephrine
                       5.3.1. Epinephrine Market, 2018 - 2030 (USD Million)
                   5.4. Immunotherapies
                       5.4.1. Immunotherapies Market, 2018 - 2030 (USD Million)
                   5.5. Others
                       5.5.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. Distribution Channel Business Analysis
                   6.1. Peanut Allergy Treatment Market: Distribution Channel Movement Analysis
                   6.2. Hospital Pharmacy
                       6.2.1. Hospital Pharmacy Market, 2018 - 2030 (USD Million)
                   6.3. Retail Pharmacy
                       6.3.1. Retail Pharmacy Market, 2018 - 2030 (USD Million)
                   6.4. Others
                       6.4.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7. Regional Business Analysis
                   7.1. Peanut Allergy Treatment Market Share By Region, 2023 & 2030
                   7.2. North America
                       7.2.1. SWOT Analysis
                       7.2.2. North America Peanut Allergy Treatment Market, 2018 - 2030 (USD Million)
                       7.2.3. U.S.
                           7.2.3.1. Key Country Dynamics
                           7.2.3.2. Target Disease Prevalence
                           7.2.3.3. Competitive Scenario
                           7.2.3.4. Regulatory Framework
                           7.2.3.5. Reimbursement Scenario
                           7.2.3.6. U.S. Peanut Allergy Treatment market, 2018 - 2030 (USD MILLION)
                       7.2.4. Canada
                           7.2.4.1. Key Country Dynamics
                           7.2.4.2. Target Disease Prevalence
                           7.2.4.3. Competitive Scenario
                           7.2.4.4. Regulatory Framework
                           7.2.4.5. Reimbursement Scenario
                           7.2.4.6. Canada Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
                   7.3. Europe
                       7.3.1. SWOT Analysis
                       7.3.2. Europe Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
                       7.3.3. Germany
                           7.3.3.1. Key Country Dynamics
                           7.3.3.2. Target Disease Prevalence
                           7.3.3.3. Competitive Scenario
                           7.3.3.4. Regulatory Framework
                           7.3.3.5. Reimbursement Scenario
                           7.3.3.6. Germany Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
                       7.3.4. UK
                           7.3.4.1. Key Country Dynamics
                           7.3.4.2. Target Disease Prevalence
                           7.3.4.3. Competitive Scenario
                           7.3.4.4. Regulatory Framework
                           7.3.4.5. Reimbursement Scenario
                           7.3.4.6. UK Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
                       7.3.5. France
                           7.3.5.1. Key Country Dynamics
                           7.3.5.2. Target Disease Prevalence
                           7.3.5.3. Competitive Scenario
                           7.3.5.4. Regulatory Framework
                           7.3.5.5. Reimbursement Scenario
                           7.3.5.6. France Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
                       7.3.6. Italy
                           7.3.6.1. Key Country Dynamics
                           7.3.6.2. Target Disease Prevalence
                           7.3.6.3. Competitive Scenario
                           7.3.6.4. Regulatory Framework
                           7.3.6.5. Reimbursement Scenario
                           7.3.6.6. Italy Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
                       7.3.7. Spain
                           7.3.7.1. Key Country Dynamics
                           7.3.7.2. Target Disease Prevalence
                           7.3.7.3. Competitive Scenario
                           7.3.7.4. Regulatory Framework
                           7.3.7.5. Reimbursement Scenario
                           7.3.7.6. Spain Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
                       7.3.8. Denmark
                           7.3.8.1. Key Country Dynamics
                           7.3.8.2. Target Disease Prevalence
                           7.3.8.3. Competitive Scenario
                           7.3.8.4. Regulatory Framework
                           7.3.8.5. Reimbursement Scenario
                           7.3.8.6. Denmark Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
                       7.3.9. Sweden
                           7.3.9.1. Key Country Dynamics
                           7.3.9.2. Target Disease Prevalence
                           7.3.9.3. Competitive Scenario
                           7.3.9.4. Regulatory Framework
                           7.3.9.5. Reimbursement Scenario
                           7.3.9.6. Sweden Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
                       7.3.10. Norway
                           7.3.10.1. Key Country Dynamics
                           7.3.10.2. Target Disease Prevalence
                           7.3.10.3. Competitive Scenario
                           7.3.10.4. Regulatory Framework
                           7.3.10.5. Reimbursement Scenario
                           7.3.10.6. Norway Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
                   7.4. Asia Pacific
                       7.4.1. SWOT Analysis
                       7.4.2. Asia Pacific Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
                       7.4.3. Japan
                           7.4.3.1. Key Country Dynamics
                           7.4.3.2. Target Disease Prevalence
                           7.4.3.3. Competitive Scenario
                           7.4.3.4. Regulatory Framework
                           7.4.3.5. Reimbursement Scenario
                           7.4.3.6. Japan Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
                       7.4.4. China
                           7.4.4.1. Key Country Dynamics
                           7.4.4.2. Target Disease Prevalence
                           7.4.4.3. Competitive Scenario
                           7.4.4.4. Regulatory Framework
                           7.4.4.5. Reimbursement Scenario
                           7.4.4.6. China Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
                       7.4.5. India
                           7.4.5.1. Key Country Dynamics
                           7.4.5.2. Target Disease Prevalence
                           7.4.5.3. Competitive Scenario
                           7.4.5.4. Regulatory Framework
                           7.4.5.5. Reimbursement Scenario
                           7.4.5.6. India Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
                       7.4.6. South Korea
                           7.4.6.1. Key Country Dynamics
                           7.4.6.2. Target Disease Prevalence
                           7.4.6.3. Competitive Scenario
                           7.4.6.4. Regulatory Framework
                           7.4.6.5. Reimbursement Scenario
                           7.4.6.6. South Korea Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
                       7.4.7. Australia
                           7.4.7.1. Key Country Dynamics
                           7.4.7.2. Target Disease Prevalence
                           7.4.7.3. Competitive Scenario
                           7.4.7.4. Regulatory Framework
                           7.4.7.5. Reimbursement Scenario
                           7.4.7.6. Australia Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
                       7.4.8. Thailand
                           7.4.8.1. Key Country Dynamics
                           7.4.8.2. Target Disease Prevalence
                           7.4.8.3. Competitive Scenario
                           7.4.8.4. Regulatory Framework
                           7.4.8.5. Reimbursement Scenario
                           7.4.8.6. Thailand Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
                   7.5. Latin America
                       7.5.1. SWOT Analysis
                       7.5.2. Latin America Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
                       7.5.3. Brazil
                           7.5.3.1. Key Country Dynamics
                           7.5.3.2. Target Disease Prevalence
                           7.5.3.3. Competitive Scenario
                           7.5.3.4. Regulatory Framework
                           7.5.3.5. Reimbursement Scenario
                           7.5.3.6. Brazil Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
                       7.5.4. Mexico
                           7.5.4.1. Key Country Dynamics
                           7.5.4.2. Target Disease Prevalence
                           7.5.4.3. Competitive Scenario
                           7.5.4.4. Regulatory Framework
                           7.5.4.5. Reimbursement Scenario
                           7.5.4.6. Mexico Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
                       7.5.5. Argentina
                           7.5.5.1. Key Country Dynamics
                           7.5.5.2. Target Disease Prevalence
                           7.5.5.3. Competitive Scenario
                           7.5.5.4. Regulatory Framework
                           7.5.5.5. Reimbursement Scenario
                           7.5.5.6. Argentina Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
                   7.6. MEA
                       7.6.1. SWOT Analysis
                       7.6.2. MEA Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
                       7.6.3. South Africa
                           7.6.3.1. Key Country Dynamics
                           7.6.3.2. Target Disease Prevalence
                           7.6.3.3. Competitive Scenario
                           7.6.3.4. Regulatory Framework
                           7.6.3.5. Reimbursement Scenario
                           7.6.3.6. South Africa Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
                       7.6.4. Saudi Arabia
                           7.6.4.1. Key Country Dynamics
                           7.6.4.2. Target Disease Prevalence
                           7.6.4.3. Competitive Scenario
                           7.6.4.4. Regulatory Framework
                           7.6.4.5. Reimbursement Scenario
                           7.6.4.6. Saudi Arabia Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
                       7.6.5. UAE
                           7.6.5.1. Key Country Dynamics
                           7.6.5.2. Target Disease Prevalence
                           7.6.5.3. Competitive Scenario
                           7.6.5.4. Regulatory Framework
                           7.6.5.5. Reimbursement Scenario
                           7.6.5.6. UAE Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
                       7.6.6. Kuwait
                           7.6.6.1. Key Country Dynamics
                           7.6.6.2. Target Disease Prevalence
                           7.6.6.3. Competitive Scenario
                           7.6.6.4. Regulatory Framework
                           7.6.6.5. Reimbursement Scenario
                           7.6.6.6. Kuwait Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
                   8.1. Participant’s overview
                   8.2. Financial performance
                   8.3. Participant categorization
                       8.3.1. Market Leaders
                       8.3.2. Peanut Allergy Treatment market Share Analysis, 2023
                       8.3.3. Company Profiles
                           8.3.3.1. Sanofi
                               8.3.3.1.1. Company Overview
                               8.3.3.1.2. Financial Performance
                               8.3.3.1.3. Product Benchmarking
                               8.3.3.1.4. Strategic Initiatives
                           8.3.3.2. Aimmune Therapeutics Inc.
                               8.3.3.2.1. Company Overview
                               8.3.3.2.2. Financial Performance
                               8.3.3.2.3. Product Benchmarking
                               8.3.3.2.4. Strategic Initiatives
                           8.3.3.3. DBV Technologies
                               8.3.3.3.1. Company Overview
                               8.3.3.3.2. Financial Performance
                               8.3.3.3.3. Product Benchmarking
                               8.3.3.3.4. Strategic Initiatives
                           8.3.3.4. Vedanta Biosciences, Inc.
                               8.3.3.4.1. Company Overview
                               8.3.3.4.2. Financial Performance
                               8.3.3.4.3. Product Benchmarking
                               8.3.3.4.4. Strategic Initiatives
                           8.3.3.5. Alladapt Immunotherapeutics, Inc.
                               8.3.3.5.1. Company Overview
                               8.3.3.5.2. Financial Performance
                               8.3.3.5.3. Product Benchmarking
                               8.3.3.5.4. Strategic Initiatives
                           8.3.3.6. Regeneron Pharmaceuticals Inc.
                               8.3.3.6.1. Company Overview
                               8.3.3.6.2. Financial Performance
                               8.3.3.6.3. Product Benchmarking
                               8.3.3.6.4. Strategic Initiatives
                           8.3.3.7. Aravax Pty Ltd
                               8.3.3.7.1. Company Overview
                               8.3.3.7.2. Financial Performance
                               8.3.3.7.3. Product Benchmarking
                               8.3.3.7.4. Strategic Initiatives
                           8.3.3.8. Prota Therapeutics
                               8.3.3.8.1. Company Overview
                               8.3.3.8.2. Financial Performance
                               8.3.3.8.3. Product Benchmarking
                               8.3.3.8.4. Strategic Initiatives
                           8.3.3.9. Teva Pharmaceuticals Industries Ltd.
                               8.3.3.9.1. Company Overview
                               8.3.3.9.2. Financial Performance
                               8.3.3.9.3. Product Benchmarking
                               8.3.3.9.4. Strategic Initiatives
                       8.3.4. Strategy Mapping
                           8.3.4.1. Expansion
                           8.3.4.2. Acquisition
                           8.3.4.3. Collaborations
                           8.3.4.4. Route Of Administration/Drug Class Launch
                           8.3.4.5. Partnerships
                           8.3.4.6. Others

List of Tables

Table 1 List of Abbreviations
Table 2 Global Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 3 Global Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 4 Global Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 5 Global Peanut Allergy Treatment Market, by Region, 2018 - 2030 (USD Million)
Table 6 North America peanut Allergy Treatment Market, by Country, 2018 - 2030 (USD Million)
Table 7 North America peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 8 North America peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 9 North America peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 10 U.S. Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 11 U.S. Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 12 U.S. Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 13 Canada Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 14 Canada Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 15 Canada Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 16 Europe Peanut Allergy Treatment Market, by Country, 2018 - 2030 (USD Million)
Table 17 Europe Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 18 Europe peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 19 Europe peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 20 Germany Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 21 Germany Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 22 Germany Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 23 UK Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 24 UK Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 25 UK Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 26 France Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 27 France Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 28 France Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 29 Italy Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 30 Italy Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 31 Italy Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 32 Spain Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 33 Spain Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 34 Spain Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 35 Denmark Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 36 Denmark Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 37 Denmark Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 38 Sweden Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 39 Sweden Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 40 Sweden Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 41 Norway Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 42 Norway Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 43 Norway Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 44 Asia Pacific peanut Allergy Treatment Market, by Country, 2018 - 2030 (USD Million)
Table 45 Asia Pacific peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 46 Asia Pacific peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 47 Asia Pacific peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 48 China Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 49 China Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 50 China Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 51 Japan Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 52 Japan Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 53 Japan Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 54 India Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 55 India Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 56 India Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 57 South Korea Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 58 South Korea Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 59 South Korea Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 60 Australia Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 61 Australia Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 62 Australia Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 63 Thailand Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 64 Thailand Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 65 Thailand Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 66 Latin America peanut Allergy Treatment Market, by Country, 2018 - 2030 (USD Million)
Table 67 Latin America peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 68 Latin America peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 69 Latin America peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 70 Brazil Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 71 Brazil Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 72 Brazil Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 73 Mexico Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 74 Mexico Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 75 Mexico Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 76 Argentina Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 77 Argentina Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 78 Argentina Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 79 Middle East & Africa peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 83 South Africa Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 84 South Africa Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 85 South Africa Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 89 UAE Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 90 UAE Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 91 UAE Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 92 Kuwait Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 93 Kuwait Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 94 Kuwait Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Peanut allergy treatment market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market snapshot
Fig. 10 Route of administration and distribution channel segment snapshot
Fig. 11 Drug class segment snapshot
Fig. 12 Competitive landscape snapshot
Fig. 13 Allergy diagnostics and therapeutics market value, 2023 (USD billion)
Fig. 14 Market dynamics
Fig. 15 Porter’s five forces analysis
Fig. 16 PESTLE analysis
Fig. 17 KOLs perspective
Fig. 18 KOLs perspective
Fig. 19 KOLs perspective
Fig. 20 Peanut allergy treatment market: Route of administration outlook and key takeaways
Fig. 21 Peanut allergy treatment market: Route of administration movement analysis
Fig. 22 Injectable market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Oral market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Peanut allergy treatment market: Drug class outlook and key takeaways
Fig. 26 Peanut allergy treatment market: Drug class movement analysis
Fig. 27 Antihistamines market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Epinephrine market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Immunotherapies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Peanut allergy treatment market: Distribution channel outlook and key takeaways
Fig. 32 Peanut allergy treatment market: Distribution channel movement analysis
Fig. 33 Hospital pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Retail pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Peanut allergy treatment market revenue, by region, 2023 & 2030 (USD Million)2023 & 2030 (USD Million)2023 & 2030 (USD Million)
Fig. 37 Regional marketplace: Key takeaways
Fig. 38 Regional marketplace: Key takeaways
Fig. 39 North America peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Key country dynamics
Fig. 41 U.S. peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 U.S. healthcare system: Money flow
Fig. 43 Key country dynamics
Fig. 44 Canada peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Drug pricing
Fig. 65 Asia Pacific peanut allergy treatment market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 66 Key country dynamics
Fig. 67 Japan peanut allergy treatment market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 Japan pharmaceutical registration
Fig. 69 Key country dynamics
Fig. 70 China peanut allergy treatment market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 71 Regulatory details: China
Fig. 72 Exclusivity formula
Fig. 73 Key country dynamics
Fig. 74 India peanut allergy treatment market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 75 Registration details: India
Fig. 76 Key country dynamics
Fig. 77 Australia peanut allergy treatment market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 78 Drug pricing: Australia
Fig. 79 Contribution of PBS by disease
Fig. 80 Key country dynamics
Fig. 81 Thailand peanut allergy treatment market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 82 Key country dynamics
Fig. 83 South Korea peanut allergy treatment market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 84 Reimbursement scenario: South Korea
Fig. 85 Rest of Asia Pacific peanut allergy treatment market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 86 Latin America peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 87 Key country dynamics
Fig. 88 Brazil peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 89 Key country dynamics
Fig. 90 Mexico peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 91 Regulatory framework
Fig. 92 Reimbursement scenario
Fig. 93 Key country dynamics
Fig. 94 Argentina peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 95 Argentina pharmaceuticals registration details
Fig. 96 Argentina pharmaceuticals reimbursement details
Fig. 97 Rest of Latin America peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 98 Middle East and Africa peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 99 Key country dynamics
Fig. 100 South Africa peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 101 Regulatory framework: South Africa
Fig. 102 Regulatory framework: South Africa drug registration fees
Fig. 103 Key country dynamics
Fig. 104 Saudi Arabia peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 105 Key country dynamics
Fig. 106 UAE peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 107 Key country dynamics
Fig. 108 Kuwait peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 109 Regulatory framework: South Africa
Fig. 110 Rest of MEA peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)